Long-term mortality and epilepsy in patients after brain abscess: A nationwide population-based matched cohort study.
To determine long-term risks of mortality and new-onset epilepsy after brain abscess. Using nationwide population-based medical registries, we examined all patients with first-time brain abscess in Denmark, 1982-2016. Comparison cohorts individually matched on age, sex and residence were identified, as were siblings of all study participants. Next, we computed cumulative incidences and hazard rate ratios (HRRs) with 95% CIs of mortality and new-onset epilepsy among study populations. We identified 1,384 brain abscess patients (37% females) with a median follow-up time of 5.9 years (IQR 1.1-14.2). The 1-year, 2-5 year, and 6-30 year mortality of patients after brain abscess was 21%, 16% and 27% as compared to 1%, 6% and 20% for population controls. Cox regression analyses adjusted for Charlson comorbidity index score showed 1-year, 2-5 year, and 6-30 year HRRs of 17.5 (13.9-22.0), 2.61 (2.16-3.16) and 1.94 (1.62-2.31). The mortality in brain abscess patients was significantly increased regardless of sex or age group except among subjects 80 years or older, and in both previously healthy individuals and immuno-compromised persons.Among the 30-day survivors of brain abscess (median follow up 7.6 years [IQR 2.2-15.5]), new-onset epilepsy occurred in 32% compared to 2% in matched population controls. Cause-specific Cox regression analysis adjusted for stroke, head trauma, alcohol abuse, and cancer showed 1-year, 2-5 year, and 6-30 year HRRs for new-onset epilepsy of 155 (78.8-304), 37.7 (23.0-59.9), and 8.93 (5.62-14.2). Brain abscess is associated with an increased long-term risk of mortality and new-onset epilepsy for several years after infection.